Transformation Capital

company

About

Transformation Capital is a growth equity fund 100% focused on innovative healthcare IT and services companies.

  • 11 - 50

Details

Industries
Finance,Financial Services,Health Care,Venture Capital
Founded date
Jan 1, 2019
Number Of Employee
11 - 50
Operating Status
Active
Investor Type
Venture Capital

Transformation Capital is the successor management company to Leerink Transformation Partners LLC (“LTP”).11 LTP was founded in 2016 by Todd Cozzens and Jared Kesselheim, MD together with SVB Leerink Capital LLC (formerly Leerink Capital Partners LLC) (“Leerink Capital”), an affiliate of SVB Leerink LLC (“Leerink”), a leading healthcare investment bank. Leerink Capital provided seed capital to Fund I (approximately 3% of capital commitments) and operational support. In January of 2019, SVB Financial Group (“SVB”), the holding company of Silicon Valley Bank, a U.S.-based high-tech commercial bank, acquired the Leerink businesses including Leerink Capital. Todd Cozzens, Jared Kesselheim, MD and SVB expect to agree to a mutually beneficial ongoing relationship in which Transformation Capital (as an independent management company owned by Todd Cozzens, Jared Kesselheim, MD and Michael Dixon and not affiliated with SVB or Leerink Capital) shall manage Fund II and whereby Transformation Capital shall manage Fund I’s investment portfolio pursuant to a sub-advisory agreement with SVB (or an affiliate). Transformation Capital has the same operational leader, Kevin Brown, formerly CFO of Leerink Capital, and Transformation Capital expects to continue to derive benefits from its ongoing relationship with Leerink and SVB.

Investments

Number of Investments
Number of Lead Investments
8
4
Transformation Capital has made 8 investments. Their most recent investment was on Sep 29, 2022, when Grow Therapy raised $45M.
Date Company Name
Round Money Raised Industry Lead Investor
Sep 29, 2022 Grow Therapy
Series B $45M Health Care Yes
Jul 6, 2022 Tebra
Series B $72M Electronic Health Record (EHR)
Jun 13, 2022 Capital Rx
Series C $106M Health Care
Mar 1, 2022 Nayya
Series C $55M Artificial Intelligence
Series C $105M Biotechnology Yes